For decades, the pharmaceutical industry operated under a singular, relentless mandate: efficiency. Pharmaceutical consultants have
Managing the lifecycle of Investigational Medicinal Products (IMP) requires more than just logistics; it demands
Our latest episode from The DES Pharma podcast explores the rapidly changing trade policy landscape
This guide establishes a clear, phase-appropriate framework for how Analytical Development (AD) and Quality Control
Navigate U.S. tariffs and pharmaceutical supply chains in 2026 — Section 232, IEEPA, USMCA, MFN
Analytical Development vs Process Development: Integrated CMC Strategy Across Drug Development Phases In pharmaceutical and
Executive Summary: Defining the New Bio Pharma Supply Chain Strategy The pharmaceutical supply chain in
Introduction The pharmaceutical supply chain landscape in 2026 continues to evolve at an unprecedented pace.
Start building reliable, high-quality drug development programs today.